ATE389727T1 - Modulatoren der expression von morphogenen und deren identifizierungsverfahren - Google Patents

Modulatoren der expression von morphogenen und deren identifizierungsverfahren

Info

Publication number
ATE389727T1
ATE389727T1 AT98925035T AT98925035T ATE389727T1 AT E389727 T1 ATE389727 T1 AT E389727T1 AT 98925035 T AT98925035 T AT 98925035T AT 98925035 T AT98925035 T AT 98925035T AT E389727 T1 ATE389727 T1 AT E389727T1
Authority
AT
Austria
Prior art keywords
expression
morphogens
modulators
identification methods
specific
Prior art date
Application number
AT98925035T
Other languages
English (en)
Inventor
Haimanti Dorai
Alyssa Shepard
Kuber Sampath
Herman Oppermann
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc filed Critical Curis Inc
Application granted granted Critical
Publication of ATE389727T1 publication Critical patent/ATE389727T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Holo Graphy (AREA)
  • Liquid Crystal (AREA)
  • Indexing, Searching, Synchronizing, And The Amount Of Synchronization Travel Of Record Carriers (AREA)
AT98925035T 1997-05-29 1998-05-28 Modulatoren der expression von morphogenen und deren identifizierungsverfahren ATE389727T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4791197P 1997-05-29 1997-05-29

Publications (1)

Publication Number Publication Date
ATE389727T1 true ATE389727T1 (de) 2008-04-15

Family

ID=21951710

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98925035T ATE389727T1 (de) 1997-05-29 1998-05-28 Modulatoren der expression von morphogenen und deren identifizierungsverfahren

Country Status (8)

Country Link
US (2) US6828095B1 (de)
EP (1) EP0985045B1 (de)
JP (1) JP2001517092A (de)
AT (1) ATE389727T1 (de)
AU (1) AU745514B2 (de)
CA (1) CA2291510A1 (de)
DE (1) DE69839265D1 (de)
WO (1) WO1998054344A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11313675A (ja) * 1998-04-30 1999-11-16 Hoechst Marion Roussel Kk ヒトｂｍｐ−７プロモーターおよびこれを用いた骨関連物質の探索法
US6368787B1 (en) * 1999-12-16 2002-04-09 Stryker Corporation Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
CN1320618A (zh) * 2000-04-27 2001-11-07 上海博德基因开发有限公司 一种新的多肽——人Pax蛋白12.5和编码这种多肽的多核苷酸
CN1321664A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人Pax蛋白23和编码这种多肽的多核苷酸
CN1322755A (zh) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 一种新的多肽——人Pax蛋白9和编码这种多肽的多核苷酸

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641743A (en) * 1988-01-25 1997-06-24 American Cyanamid Company Therapeutic compositions and methods for use of heparin-binding brain mitogens
JPH06502532A (ja) * 1990-10-10 1994-03-24 ラ　ジョラ　キャンサー　リサーチ　ファウンデーション 核受容体を用いた転写抑制の方法
US5169837A (en) * 1991-03-28 1992-12-08 Allelix Biopharmaceuticals Inc. Isolated osteogenic factor
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
EP0804573A1 (de) 1994-06-07 1997-11-05 Creative Biomolecules, Inc. Methoden und zusammensetzungen zur modulation morphogener zellexpression
US6083690A (en) 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents

Also Published As

Publication number Publication date
JP2001517092A (ja) 2001-10-02
WO1998054344A2 (en) 1998-12-03
AU7707398A (en) 1998-12-30
CA2291510A1 (en) 1998-12-03
US6828095B1 (en) 2004-12-07
EP0985045B1 (de) 2008-03-19
WO1998054344A3 (en) 1999-02-25
DE69839265D1 (de) 2008-04-30
AU745514B2 (en) 2002-03-21
EP0985045A2 (de) 2000-03-15
US20050208533A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
EP1003916A4 (de) Antisense oligonukleotidzusammensetzungensowie verfahren zur modulation von jnk proteinen
ATE248150T1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
DE69831589D1 (de) Zusammenfügung von knorpelmatrizen unter verwendung isolierter chondrozyten
DE69626015D1 (de) Verfahren zur identifizierung von knochenwachstum modulatoren
EP1131465A4 (de) Antisense-modulierung der interleukin-15 expression
DK0920498T3 (da) Hamster EF-1alfa transskriptionelt, regulatorisk DNA
ATE345682T1 (de) In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
ATE352639T1 (de) Antisense modulation der expression von integrin alpha 4
DE69941576D1 (de) Antisense-modulation der survivin-expression
ATE428780T1 (de) Verfahren zur zubereitung von antisense oligonukleotiden
ATE367448T1 (de) Zusammensetzung enthaltend nukleinsäuren und kationische polymere, zubereitung und verwendung
BR9607273A (pt) Molécula de dna duplo filamento dna recombinante plasmídio célula recombinante composiçao farmacéutica e processo de preparaçao de uma molécula de dna
DE59505022D1 (de) Verfahren zur Racemisierung von Enantiomeren der alpha-Liponsäure
EP1135402A4 (de) Antisense modulation der egr-1 expression
EP1189918A4 (de) Antisense-modulation der integrin-beta-3-expression
MY138257A (en) Compositions and methods for enhancing delivery of therapeutic agents to cells
TR199802648A3 (tr) Gen tedavisi için nüklein asit yapilari.
DE69823372T8 (de) Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
ATE373083T1 (de) Methode und zusammensetzungen zur identifizierung von morphogen-analogen
ATE389727T1 (de) Modulatoren der expression von morphogenen und deren identifizierungsverfahren
DK0904282T3 (da) Hidtil ukendte kationiske cholesterylderivater indeholdende cykliske polære grupper
ATE305037T1 (de) Peptide, die fähig sind die sh3-domäne des gap- proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung
DE69739346D1 (de) Gereinigtes sr-p70 protein
ATE214708T1 (de) Kationische mittel zur transfektion von nukleinsäuren